This study evaluates cardiac biomarkers and their association to coronary artery disease in marathon runners.
The MaraCat study is an observational prospective study evaluating the association between cardiac biomarkers and coronary artery disease in 43 runners participating in the 2018 Paavo Nurmi Marathon. The study participants were recruited according to two age criteria - under 35 years and over 44 years of age. Comprehensive laboratory samples were collected immediately after the run, while the control workup was done in a separate visit with no significant physical excercise in the preceding two weeks. In the under 35 years -group, the control workup included an echocardiography, ecg and blood samples. In the over 44 years group, the control studies included coronary CT, echocardiography, ecg and laboratory tests.
Study Type
OBSERVATIONAL
Enrollment
43
Turku University Hospital, Heart Center
Turku, Finland
Cardiac Troponin-T level after marathon
Cardiac troponin-T levels (ng/L), \[electrochemiluminescence (ECLIA) method\]
Time frame: 0-30minutes after finishing the Paavo Nurmi Marathon
Association Cardiac troponin-T level and coronary CT findings
Cardiac troponin-T levels (ng/L), \[electrochemiluminescence (ECLIA) method\]
Time frame: Cardiac Troponin-T 0-30 minutes after finishing the Paavo Nurmi Marathon. Control Troponin-T levels and coronary CT angiography at control visit (>30days after marathon).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.